NCT05894746 Gfree - For Improved Blood Sugar and Reduced Inflammation.
| NCT ID | NCT05894746 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Göteborg University |
| Condition | Diabetes |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2023-05-04 |
| Primary Completion | 2025-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2023-05-04 with a primary completion date of 2025-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to reduce inflammation and improve glycemic control in healthy volunteers, parents, as well as children, adolescents and adults with or without diabetes. The main questions it aims to answer are: • does a reduction wheat gluten improve glycemic control and/or inflammatory biomarkers • does a reduction in certain amino acids (which is most common in wheat gluten) improve glycemic control and/or inflammatory biomarkers • can we identify individuals with an inflammatory response, which leads to poor glycemic control. Participants will eat gluten-free products as well as similar products containing gluten. They will also eat gluten together with probiotics to see if an effect of gluten can be reduced. Researchers will compare everyone with themselves (cross-over design) and if possible individuals with and without diabetes.
Eligibility Criteria
Inclusion Criteria: \- none Exclusion Criteria: \- A diagnosis of celiac disease
Contact & Investigator
Åsa Torinsson Naluai, PhD
PRINCIPAL INVESTIGATOR
Göteborg University
Frequently Asked Questions
Who can join the NCT05894746 clinical trial?
This trial is open to participants of all sexes, aged 6 Years or older, studying Diabetes. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05894746 currently recruiting?
Yes, NCT05894746 is actively recruiting participants. Contact the research team at asa.torinsson.naluai@gu.se for enrollment information.
Where is the NCT05894746 trial being conducted?
This trial is being conducted at Gothenburg, Sweden, Skövde, Sweden.
Who is sponsoring the NCT05894746 clinical trial?
NCT05894746 is sponsored by Göteborg University. The principal investigator is Åsa Torinsson Naluai, PhD at Göteborg University. The trial plans to enroll 60 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.